108 related articles for article (PubMed ID: 31175745)
1. Medico-social value of osteoarthritis. secondary prevention and treatment of osteoarthritis in comorbidity with chronic gastritis.
Zak MY; Klymenko MO; Iakovenko NO; Grischenko GV
Wiad Lek; 2019; 72(5 cz 2):1064-1067. PubMed ID: 31175745
[TBL] [Abstract][Full Text] [Related]
2. [The role of chronic gastritis in past medical history with NSAID administration in patients with osteoarthrosis].
Zak MIu
Lik Sprava; 2014 Nov; (11):93-7. PubMed ID: 25528842
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
4. Superior digestive tract side effects after prolonged treatment with NSAIDs in patients with osteoarthritis.
Rogoveanu OC; Streba CT; Vere CC; Petrescu L; Trăistaru R
J Med Life; 2015; 8(4):458-61. PubMed ID: 26664470
[TBL] [Abstract][Full Text] [Related]
5. The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events.
Frezza M; Gorji N; Melato M
J Clin Pathol; 2001 Jul; 54(7):521-5. PubMed ID: 11429423
[TBL] [Abstract][Full Text] [Related]
6. Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study.
Shah K; Price AB; Talbot IC; Bardhan KD; Fenn CG; Bjarnason I
Gut; 1995 Aug; 37(2):195-8. PubMed ID: 7557567
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drug gastropathy.
Laine L
Gastrointest Endosc Clin N Am; 1996 Jul; 6(3):489-504. PubMed ID: 8803564
[TBL] [Abstract][Full Text] [Related]
9. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
[TBL] [Abstract][Full Text] [Related]
10. Use and costs of anti-secretory and cardiovascular co-medication in osteoarthritis patients treated with selective or non-selective NSAIDS.
Simoens S; De Coster S; De Ruyck B; Stutz P; Laekeman G
Pharm World Sci; 2006 Oct; 28(5):309-17. PubMed ID: 17111243
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.
Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Dequeker J; Isomäki H; Littlejohn G; Mau J; Papazoglou S
Br J Rheumatol; 1998 Sep; 37(9):937-45. PubMed ID: 9783757
[TBL] [Abstract][Full Text] [Related]
12. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
13. Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs.
Watson DJ; Bolognese JA; Yu C; Krupa D; Curtis S
Curr Med Res Opin; 2004 Dec; 20(12):1899-908. PubMed ID: 15701208
[TBL] [Abstract][Full Text] [Related]
14. The appropriate use of NSAIDs in arthritic conditions.
Moskowitz RW
Am J Orthop (Belle Mead NJ); 1996 Sep; 25(9 Suppl):4-6. PubMed ID: 8886211
[TBL] [Abstract][Full Text] [Related]
15. The use and safety profile of non-steroidal antiinflammatory drugs among Turkish patients with osteoarthritis.
Yilmaz H; Gürel S; Ozdemir O
Turk J Gastroenterol; 2005 Sep; 16(3):138-42. PubMed ID: 16245223
[TBL] [Abstract][Full Text] [Related]
16. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs.
Hudson N; Balsitis M; Filipowicz F; Hawkey CJ
Gut; 1993 Jun; 34(6):748-51. PubMed ID: 8314505
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
Layton D; Hughes K; Harris S; Shakir SA
Rheumatology (Oxford); 2003 Nov; 42(11):1332-41. PubMed ID: 12810929
[TBL] [Abstract][Full Text] [Related]
18. Chemical gastritis and Helicobacter pylori related gastritis in patients receiving non-steroidal anti-inflammatory drugs: comparison and correlation with peptic ulceration.
Taha AS; Nakshabendi I; Lee FD; Sturrock RD; Russell RI
J Clin Pathol; 1992 Feb; 45(2):135-9. PubMed ID: 1541693
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drug gastropathy and Helicobacter pylori: the search for an improbable consensus.
Lazzaroni M; Bianchi Porro G
Am J Med; 2001 Jan; 110(1A):50S-54S. PubMed ID: 11165998
[TBL] [Abstract][Full Text] [Related]
20. [Gastropathy caused by non-steroidal anti-inflammatory agents and its association with Helicobacter pylori].
Rodríguez-Hernández H; Jacobo-Karam JS; Jáquez-Quintana JO; Avila-Romero HG; Galván-Román L; Lara-Miranda SC; Sánchez-Anguiano LF
Rev Invest Clin; 2003; 55(3):254-9. PubMed ID: 14515669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
